- Home
- FBIOP vs ACGLO Comparison
FBIOP vs ACGLO Comparison
Compare FBIOP & ACGLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- ACGLO
- Stock Information
- Founded
- FBIOP N/A
- ACGLO N/A
- Country
- FBIOP United States
- ACGLO Bermuda
- Employees
- FBIOP 101
- ACGLO 5800
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- ACGLO Property-Casualty Insurers
- Sector
- FBIOP Health Care
- ACGLO Finance
- Exchange
- FBIOP Nasdaq
- ACGLO Nasdaq
- Market Cap
- FBIOP N/A
- ACGLO N/A
- IPO Year
- FBIOP N/A
- ACGLO N/A
- Fundamental
- Price
- FBIOP $9.47
- ACGLO $20.52
- Analyst Decision
- FBIOP
- ACGLO
- Analyst Count
- FBIOP 0
- ACGLO 0
- Target Price
- FBIOP N/A
- ACGLO N/A
- AVG Volume (30 Days)
- FBIOP N/A
- ACGLO N/A
- Earning Date
- FBIOP N/A
- ACGLO N/A
- Dividend Yield
- FBIOP N/A
- ACGLO N/A
- EPS Growth
- FBIOP N/A
- ACGLO N/A
- EPS
- FBIOP N/A
- ACGLO N/A
- Revenue
- FBIOP N/A
- ACGLO N/A
- Revenue This Year
- FBIOP N/A
- ACGLO N/A
- Revenue Next Year
- FBIOP N/A
- ACGLO N/A
- P/E Ratio
- FBIOP N/A
- ACGLO N/A
- Revenue Growth
- FBIOP N/A
- ACGLO N/A
- 52 Week Low
- FBIOP N/A
- ACGLO N/A
- 52 Week High
- FBIOP N/A
- ACGLO N/A
- Technical
- Relative Strength Index (RSI)
- FBIOP 85.14
- ACGLO 49.32
- Support Level
- FBIOP $6.43
- ACGLO $20.32
- Resistance Level
- FBIOP $7.00
- ACGLO $20.72
- Average True Range (ATR)
- FBIOP 0.41
- ACGLO 0.17
- MACD
- FBIOP 0.25
- ACGLO 0.02
- Stochastic Oscillator
- FBIOP 99.37
- ACGLO 51.43
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.